Granules India, through its subsidiary Granules Pharmaceuticals Inc. (GPI), is dedicated to delivering cost-effective and high-quality pharmaceutical products. Located in Chantilly, Virginia, GPI operates as a US FDA and DEA approved facility.

With over 100,000 square feet of space, GPI houses state-of-the-art R&D and manufacturing capabilities for low volume, oral solid dosage forms. Under the GPI label, the company also distributes its products to ensure accessibility and continuity. Their diverse portfolio consists of low and medium to high volume products, including tablets, capsules, oral solutions, and powders for oral solutions.

These products are manufactured at their Chantilly facility and other finished dosage sites in India. GPI prides itself on its advanced manufacturing capabilities, which include immediate and modified release dosage forms, orally disintegrating modified release forms, chewable modified release forms, and more. They also specialize in patentable technology platforms, such as microspheres.

With a strong focus on growth and innovation, Granules Pharmaceuticals Inc. They continue to expand their team of over 150 employees, working towards a healthier world. Contact GPI today to explore career opportunities or learn more about their products and services